Patents by Inventor Donald Wesson

Donald Wesson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240116207
    Abstract: A sealant spreader device fills voids around a drilled hole with sealant in glued-in-rod (GIR) structures. A liquid sealant may be applied to the base of a drilled hole. A sealant spreader device is then inserted to the base of the drilled hole, through the sealant. The sealant spreader device is then withdrawn while rotating. The sealant spreader device includes winged sections having contours which force the sealant radially outward toward walls of the hole, into any voids around the circumference of the drilled hole, and leaves a thin layer of sealant around the circumference of the drilled hole.
    Type: Application
    Filed: October 6, 2022
    Publication date: April 11, 2024
    Applicant: Simpson Strong-Tie Company Inc.
    Inventors: Steven E. Pryor, Emory L. Montague, Guy T. Anderson, Quentin Hibben, Corey Clark, Marlou Rodriguez, Randy Daudet, Robert Leichti, Paul McEntee, Michael Wesson, Donald Weems, Von Yang
  • Patent number: 8012958
    Abstract: The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. In one treatment method, methods of, and compositions for, modulating the expression of certain GABAA receptor subunits are used to treat anxiety-related disorders and depressive disorders associated with physiological tolerance to endogenous neurosteroids.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: September 6, 2011
    Assignee: Hythlam, Inc.
    Inventors: Sanjay Sabnani, Donald Wesson
  • Publication number: 20080280885
    Abstract: The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. In one treatment method, methods of, and compositions for, modulating the expression of certain GABAA receptor subunits are used to treat anxiety-related disorders and depressive disorders associated with physiological tolerance to endogenous neurosteroids.
    Type: Application
    Filed: April 7, 2006
    Publication date: November 13, 2008
    Applicant: Hythiam, INC.
    Inventors: Sanjay Sabnani, Donald Wesson
  • Publication number: 20080255097
    Abstract: The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. More specifically, the present invention relates to methods of and compositions for treating and relieving symptoms associated with substance abuse and withdrawal. The present invention relates to methods of and compositions for treating and relieving symptoms associated with addiction to antidepressants, opiates, nicotine or marijuana. In one method, a patient is treated with a composition that directly or indirectly modulates GABAA by modulating the expression of the GABAA receptor a4 subunit.
    Type: Application
    Filed: April 7, 2006
    Publication date: October 16, 2008
    Applicant: Hythiam, Inc.
    Inventors: Sanjay Sabnani, Donald Wesson, Joseph Dunn